Ofstead & Associates, Inc, St. Paul, MN.
Ofstead & Associates, Inc, St. Paul, MN.
Am J Infect Control. 2020 Mar;48(3):309-315. doi: 10.1016/j.ajic.2019.09.013. Epub 2019 Oct 31.
Endoscope reprocessing is often ineffective, and microbes frequently remain on endoscopes after the use of high-level disinfectants (HLDs). Several factors impact reprocessing effectiveness, including non-adherence to guidelines, use of damaged endoscopes, use of insoluble products during endoscopy, insufficient cleaning, contaminated rinse water, and inadequate drying before storage. Our team suspected that issues with HLD chemistries and monitoring could also contribute to reprocessing failures. We conducted a mixed-methods analysis of published literature, our interviews with frontline personnel, and evidence from our previous studies. The evidence showed that reusable HLDs commonly failed tests for minimum effective concentration (MEC) before their maximum usage periods. MEC tests also detected failures associated with single-use HLDs that did not fully deploy. These failures were due to product issues, process complexities, and personnel non-adherence with guidelines and manufacturer instructions. HLDs will likely continue to be used for the foreseeable future. More research is needed to assess real-world practice patterns related to the high-level disinfection step and MEC testing and to establish more realistic usage periods for reusable HLD chemistries. Manufacturers and researchers should evaluate the ability of technological solutions and engineered safeguards to overcome human error. Recognition of the need for quality improvement is growing, and infection preventionists should take action to build on this momentum and collaborate with manufacturers, endoscopists, and reprocessing personnel to improve the effectiveness of high-level disinfection.
内镜再处理通常效果不佳,即使使用高水平消毒剂 (HLD) 后,微生物仍经常残留在内镜上。有几个因素会影响再处理效果,包括不遵守指南、使用损坏的内镜、在内镜检查过程中使用不溶性产品、清洗不充分、冲洗水受到污染以及储存前干燥不充分。我们的团队怀疑 HLD 化学物质和监测方面的问题也可能导致再处理失败。我们对已发表的文献、我们与一线人员的访谈以及我们之前研究的证据进行了混合方法分析。证据表明,在达到最大使用期限之前,可重复使用的 HLD 通常会在最小有效浓度 (MEC) 测试中失败。MEC 测试还检测到与未完全展开的一次性 HLD 相关的失败。这些失败是由于产品问题、工艺复杂性以及人员不遵守指南和制造商说明造成的。在可预见的未来,HLD 可能会继续使用。需要更多的研究来评估与高水平消毒步骤和 MEC 测试相关的实际实践模式,并为可重复使用的 HLD 化学物质建立更现实的使用期限。制造商和研究人员应评估技术解决方案和工程保障措施克服人为错误的能力。对质量改进的需求正在增加,感染预防人员应采取行动,利用这一势头,与制造商、内镜医生和再处理人员合作,提高高水平消毒的效果。